Seminal vesicles

Labroots Announces One-Day Agenda at its 5th Annual Cell Biology Online Event

Retrieved on: 
Thursday, September 16, 2021
Knowledge, Liver, Science, Seminal vesicles, Continuing education, Cell biology, Alport syndrome, Molecular biology, Social, Therapy, Neoplasm, Biochemistry, Learning, Time, Research, Social media, Pancreas, News, Pharmaceutical industry, Online shopping

The informative agenda will introduce the latest scientific findings and highlight some of the brightest minds in the field, while exploring sessions on Basic Cell Biology, Translational Cell Biology, Quantitative Cell Biology, and Extracellular Vesicles.

Key Points: 
  • The informative agenda will introduce the latest scientific findings and highlight some of the brightest minds in the field, while exploring sessions on Basic Cell Biology, Translational Cell Biology, Quantitative Cell Biology, and Extracellular Vesicles.
  • "We are delighted to produce Cell Biology 2021 for the 5th consecutive year revealing novel approaches and new knowledge for the better understanding of cell biology in research."
  • Produced on Labroots' highly interactive platform allowing the capability to connect seamlessly across all desktops and mobile devices, the online event delivers a comprehensive educational experience.
  • Join the online conversation and use the official event hashtag #LRcellbio to stay up to date on the latest information.

Forever Labs to Utilize Data Collection Platform DataBiologics

Retrieved on: 
Tuesday, September 14, 2021
Forever Labs, ANN, Safety, Physician, GLOBE, EVS, Medicine, PPP, Health, Seminal vesicles, Review, PRP, Pharmaceutical industry

ANN ARBOR, Mich., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Forever Labs , the parent company of SuperShot PRP , will utilize DataBiologics to track outcomes for their innovative PRP process that allows autologous extracellular vesicles to be isolated.

Key Points: 
  • ANN ARBOR, Mich., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Forever Labs , the parent company of SuperShot PRP , will utilize DataBiologics to track outcomes for their innovative PRP process that allows autologous extracellular vesicles to be isolated.
  • Physicians who already collect, review and analyze data related to their orthobiologic treatment outcomes via the DataBiologics platform, can now include SuperShot PRP procedures in their data.
  • By using DataBiologics, Forever Labs is ensuring that the safety and efficacy of SuperShot PRP are tracked and monitored, a top priority for the Forever Labs team.
  • DataBiologics offers doctors a robust patient-reported outcomes collection platform to study the safety and efficacy of orthobiologic treatments.

Evelo Biosciences Announces Issuance of U.S. Patent for Pharmaceutical Compositions of Single Strains of Naturally Occurring Bacteria as Medicines

Retrieved on: 
Thursday, September 9, 2021

11,090,341) for medicines comprising pharmaceutical compositions of Veillonella parvula bacteria.

Key Points: 
  • 11,090,341) for medicines comprising pharmaceutical compositions of Veillonella parvula bacteria.
  • The grant of this patent is further confirmation that pharmaceutical compositions containing single strains of naturally occurring bacteria selected for their potential therapeutic properties are patent-eligible, said Dr. Mark Bodmer, Chief Scientific Officer and President of R&D of Evelo.
  • These compositions do not occur in nature and so are patentable in a similar way to more conventional novel medicines.
  • The patent specification also discloses the use of extracellular vesicles (EVs) derived from Veillonella as orally-delivered medicines, continued Dr. Bodmer.

NanoView Biosciences Announces Key Appointments to Scientific Advisory Board

Retrieved on: 
Thursday, August 19, 2021
Company, IPSC, Journal, University, Lysogenic cycle, Cancer, Prognosis, ISEV, Research, Diagnosis, Exosome, Biomarker, RNA, Culture Collection (University of Gothenburg), Disease, JEV, Therapy, Central nervous system, Seminal vesicles, Cell, Inflammation, Nanomedicine, Coronavirus Scientific Advisory Board (Turkey), International Society, International Society for Extracellular Vesicles, DVM, Patient, Journal of Extracellular Vesicles, CEO, Pharmacology, Technology, Pharmaceutical industry

BOSTON, Aug. 19, 2021 /PRNewswire/ --NanoView Biosciences today announced the appointment of Prof. Jan Ltvall, M.D., Ph.D., and Mark Plavsic, DVM, Ph.D., to its Scientific Advisory Board.

Key Points: 
  • BOSTON, Aug. 19, 2021 /PRNewswire/ --NanoView Biosciences today announced the appointment of Prof. Jan Ltvall, M.D., Ph.D., and Mark Plavsic, DVM, Ph.D., to its Scientific Advisory Board.
  • Jan Ltvall is a Professor at the University of Gothenburg in Sweden where he directs a research laboratory studying extracellular vesicles.
  • He is a medical specialist in both Clinical Allergy and Clinical Pharmacology, and has extensive experience in translational studies in inflammation and cancer.
  • I am excited to advise NanoView as it delivers unique products and services to advance this rapidly expanding field of nanomedicine," stated Prof. Ltvall.

New BD Benchtop Cell Analyzer Enhances Laboratory Access and Accelerates Scientific Research

Retrieved on: 
Wednesday, August 11, 2021
Therapy, Health, Safety, Company, LinkedIn, Patient, Efficiency, Becton, Dickinson and Company headquarters, FACS, BD, Partnership, Organization, Technology, Immunophenotyping, Solution, Analyser, NYSE, Research, Twitter, Sorter, Seminal vesicles, Flow cytometry, BDX, Acquisition, Laboratory, Disease, Becton, Pharmaceutical industry, Computer data storage

The new BD FACSymphony A1 Cell Analyzeris a fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, which helps improve access to instrumentation for complex scientific research to more labs.

Key Points: 
  • The new BD FACSymphony A1 Cell Analyzeris a fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, which helps improve access to instrumentation for complex scientific research to more labs.
  • "We know from our customers that research time and resource allocation are critically important factors in determining the most appropriate cell analyzer to perform their work," said Puneet Sarin, worldwide president of BD Biosciences.
  • This BD FACSymphony A1 Cell Analyzer features BD FACSymphony instrument technology with the flexibility to meet a broad spectrum of research needs from small particle research to 16-color immunophenotyping, along with industry-standard BD FACSDiva Software for streamlined workflows from system setup to data acquisition and analysis.
  • Along with BD flow cytometry reagents and acquisition and analysis software and informatics tools, BD provides a complete solution for all cell analysis needs.

Biological Dynamics to Present at UBS Genomics 2.0 and MedTech Innovations Summit

Retrieved on: 
Friday, August 6, 2021
Research, Technology, Genetics, Other Technology, Nanotechnology, Other Health, Biotechnology, Health, Science, Oncology, Seminal vesicles, Exosome, Nanoparticle, Biomarker, Technology, Cancer, Genomics, UBS, Professor, Blood, Biology, Machine learning, CFO, Twitter, Biological Dynamics of Forest Fragments Project Area of Relevant Ecological Interest, Saint John, Medical imaging

Biological Dynamics, Inc., a next-generation liquid biopsy company focused on detecting cancers at the earliest stages, will present at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California.

Key Points: 
  • Biological Dynamics, Inc., a next-generation liquid biopsy company focused on detecting cancers at the earliest stages, will present at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California.
  • The panel discussion takes place on Tuesday, August 10, 2021 at 7:00 p.m. PT.
  • To join the live webcast, visit Biological Dynamics website: https://biologicaldynamics.com/company-events .
  • Biological Dynamics, Inc. is a healthcare company committed to improving global health outcomes by detecting diseases at their earliest stages.